Your browser doesn't support javascript.
loading
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Beköz, H; Karadurmus, N; Paydas, S; Türker, A; Toptas, T; Firatli Tuglular, T; Sönmez, M; Gülbas, Z; Tekgündüz, E; Kaya, A H; Özbalak, M; Tastemir, N; Kaynar, L; Yildirim, R; Karadogan, I; Arat, M; Pepedil Tanrikulu, F; Özkocaman, V; Abali, H; Turgut, M; Kurt Yüksel, M; Özcan, M; Dogu, M H; Kabukçu Hacioglu, S; Barista, I; Demirkaya, M; Köseoglu, F D; Toprak, S K; Yilmaz, M; Demirkürek, H C; Demirkol, O; Ferhanoglu, B.
Afiliação
  • Beköz H; Division of Hematology, Department of Internal Medicine, Medical Faculty, Medipol University, Istanbul.
  • Karadurmus N; Division of Medical Oncology, Department of Internal Medicine, Gulhane Research and Training Hospital, Ankara.
  • Paydas S; Division of Medical Oncology, Department of Internal Medicine, Medical Faculty, Cukurova University, Adana.
  • Türker A; Division of Medical Oncology, Department of Internal Medicine, Medical Faculty, Hacettepe University, Ankara.
  • Toptas T; Division of Hematology, Department of Internal Medicine, Medical Faculty, Marmara University, Istanbul.
  • Firatli Tuglular T; Division of Hematology, Department of Internal Medicine, Medical Faculty, Marmara University, Istanbul.
  • Sönmez M; Division of Hematology,Department of Internal Medicine, Medical Faculty, Karadeniz Technical University, Trabzon.
  • Gülbas Z; Division of Hematology, Anadolu Medical Center, Izmit.
  • Tekgündüz E; Division of Hematology, Dr Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara.
  • Kaya AH; Division of Hematology, Dr Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara.
  • Özbalak M; Division of Internal Medicine, Bahçelievler State Hospital, Istanbul.
  • Tastemir N; Division of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul.
  • Kaynar L; Division of Hematology, Department of Internal Medicine, Medical Faculty, Erciyes University, Kayseri.
  • Yildirim R; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ataturk University, Erzurum.
  • Karadogan I; Division of Hematology, Medstar Antalya Hospital, Antalya.
  • Arat M; Division of Hematology, Florence Nighthingale Hospital, Istanbul.
  • Pepedil Tanrikulu F; Division of Hematology, Dr Turgut Noyan Research and Training Center, Baskent University, Adana.
  • Özkocaman V; Division of Hematology, Department of Internal Medicine, Medical Faculty, Uludag University, Bursa.
  • Abali H; Division of Medical Oncology, Acibadem University Medical Faculty Adana Hospital, Adana.
  • Turgut M; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ondokuz Mayis University, Samsun.
  • Kurt Yüksel M; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ankara University, Ankara.
  • Özcan M; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ankara University, Ankara.
  • Dogu MH; Division of Hematology, Istanbul Research and Training Hospital, Istanbul.
  • Kabukçu Hacioglu S; Division of Hematology, Department of Internal Medicine, Medical Faculty, Pamukkale University, Denizli.
  • Barista I; Division of Medical Oncology, Department of Internal Medicine, Medical Faculty, Hacettepe University, Ankara.
  • Demirkaya M; Division of Medical Oncology, Department of Pediatrics, Medical Faculty, Uludag University, Bursa.
  • Köseoglu FD; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ege University, Izmir.
  • Toprak SK; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ankara University, Ankara.
  • Yilmaz M; Division of Hematology, Department of Internal Medicine, Medical Faculty, Gaziantep University, Gaziantep.
  • Demirkürek HC; Division of Nuclear Medicine, V.K.V. American Hospital, Istanbul.
  • Demirkol O; Department of Nuclear Medicine, Koc University School of Medicine, Istanbul.
  • Ferhanoglu B; Division of Hematology, V.K.V. American Hospital and Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey. Electronic address: bferhan@gmail.com.
Ann Oncol ; 28(10): 2496-2502, 2017 Oct 01.
Article em En | MEDLINE | ID: mdl-28961828
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Anticorpos Monoclonais Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Anticorpos Monoclonais Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article